Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: A Pilot and Feasibility Study
Status:
Completed
Trial end date:
2020-10-03
Target enrollment:
Participant gender:
Summary
Trauma is the leading cause of death and disability in children in the United States. The
long-term goal of this project is to evaluate the benefits and harms of tranexamic acid (TXA;
a drug that stops bleeding) in severely injured children. This is a 40-patient pilot study to
evaluate the feasibility of two subsequent large-scale studies of TXA in injured children.
Phase:
Phase 2
Details
Lead Sponsor:
Daniel Nishijima, MD, MAS University of California, Davis